Expression of cyclin-dependent kinase 6 (cdk6) and frequent loss of CD44 in nasal-nasopharyngeal NK/T-cell lymphomas: Comparison with CD56-negative peripheral T-cell lymphomas

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 893-900

  Lien, Huang Chun ^a   Lin, Chun Wu ^a   Huang, Pei Hsin ^a   Chang, Min Lee ^a   Hsu, Su Ming ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CELL MARKER; CYCLIN DEPENDENT KINASE; HERMES ANTIGEN; STEM CELL FACTOR RECEPTOR; T LYMPHOCYTE RECEPTOR;

ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENE LOSS; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; MALE; NASOPHARYNX; NATURAL KILLER CELL; NOSE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; T CELL LYMPHOMA; THYMOCYTE;

EID: 0033943017     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780093     Document Type: Article

References (52)

1. Arber DA, Weiss LM, Albujar RF, Chen YY, and Jaffe ES (1993). Nasal lymphoma in Peru, high incidence of T-cell immunophenotype and Epstein-Barr virus infection. Am J Surg Pathol 17:392-399.
2. Arpin C, de Bouteiller O, Razanajaona D, Fugier-Vivier I, Briere F, Banchereau J, Lebecque S, and Liu YJ (1998). The normal counterpart of IgD myeloma cells in germinal center displays extensively mutated IgVH gene, Cμ-Cδ switch, and lambda light chain expression. J Exp Med 187:1169-1178.
3. Cannell EJ, Farrell PJ, and Sinclair AJ (1996). Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells. Oncogene 13:1413-1421.
4. Carlyle JR, Michie AM, Furlonger C, Nakano T, Lenardo MJ, Paige CJ, and Zúñiga-Pflücker JC (1997). Identification of a novel developmental stage marking lineage commitment of progenitor thymocytes. J Exp Med 186:173-182.
5. Chan JKC, Ng CS, Lau WH, and Lo STH (1987). Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am J Surg Pathol 11:418-429.
6. Chan JK, Sin VC, Wong KF, Ng CS, Tsang WY, Chan CH, Cheung MM, and Lau WH (1997). Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood 89:4501-4513.
7. Chiang AKS, Chan ACL, Srivastava G, and Ho FCS (1997). Nasal T/Natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int J Cancer 73:332-338.
8. Chiang AKS, Srivastava G, Lau PWF, and Ho FCS (1996). Differences in T-cell-receptor gene rearrangement and transcription in nasal lymphomas of natural killer and T-cell types: Implications on cellular origin. Hum Pathol 27:701-707.
9. Chilosi M, Doglioni C, Yan Z, Lestani M, Menestrina F, Sorio C, Benedetti A, Vinante F, Pizzolo G, and Inghirami G (1998). Differential expression of cyclin-dependent kinase 6 in cortical thymocytes and T-cell lymphoblastic lymphoma/ leukemia. Am J Pathol 152:209-217.
10. Delfino DV, Patrene KD, DeLeo AB, DeLeo R, Herberman RB, and Boggs SS (1994). Role of CD44 in the development of natural killer cells from precursors in long-term cultures of mouse bone marrow. J Immunol 152:5171-5179.
11. - thymocytes. Int Immunol 3:1015-1024.
12. Diss TC, Watts M, Pan LX, Burke M, Linch D, and Isaacson PG (1995). The polymerase chain reaction in the demonstration of monoclonicity in T cell lymphomas. J Clin Pathol 48:1045-1050.
13. Elenitoba-Johnson KS, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, and Jaffe ES (1998). Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. Mod Pathol 11:754-761.
14. + T-cell-receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 87: 1466-1473.
15. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, and Livingston DM (1993). Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73: 487-497.
16. + cells of patients with B-cell chronic lymphocytic leukemia. Blood 89:4275-4281.
17. Gaulard P, Henni T, Marolleau J-P, Haioun C, Henni Z, Voisin M-C, Divine M, Goossens M, Farcet J-P, and Reyes F (1988). Lethal midline granuloma (polymorphic reticulosis) and lymphomatoid granulomatosis. Evidence for a monoclonal T-cell lymphoproliferative disorder. Cancer 62:705-710.
18. - triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. J Immunol 150:4244-4252.
19. Günthert U (1993). CD44: A multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-62.
20. Haynes BF, Telen MJ, Hale LP, and Denning SM (1989). CD44-, a molecule involved in leukocyte adherence and T-cell activation. Immunol Today 10:423-428.
21. Herrlich P, Zoller M, Pals ST, and Ponta H (1993). CD44 splice variants: Metastases meet lymphocytes. Immunol Today 14:395-399.
22. Ho FCS, Choy D, Loke SL, Kung ITM, Fu KH, Liang R, Todd D, and Khoo RKK (1990a). Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: A clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum Pathol 21:1041-1050.
23. Ho FCS, Srivastava G, Loke SL, Fu KH, Leung BPY, Liang R, and Choy D (1990b). Presence of Epstein-Barr virus DNA in nasal lymphomas of B and T cell type. Hematol Oncol 8:271-281.
24. Ho FCS, Todd D, Loke SL, Ng RP, and Khoo RKK (1984). Clinico-pathological features of malignant lymphomas in 294 Hong Kong Chinese patients; retrospective study covering an eight-year period. Int J Cancer 34:143-148.
25. Horst E, Meijer CJLM, Radaskiewicz T, van Dongen JJM, Pieters R, Figdor CG, Hooftman A, and Pals ST (1990). Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development. Leukemia 4:383-389.
26. Hsu SM, Waldron AJ Jr, Xie SS, and Hsu PL (1996). Hodgkin's disease and anaplastic large cell lymphoma revisited - II. From cytokines to cell lineage. J Biomed Sci 3:1-13.
27. Ichinohasama R, Endoh K, Ishizawa K, Okuda M, Kameoka J, Meguro K, Myers J, Kadin ME, Mori S, and Sawai T (1996). Thymic lyrnphoblastic lymphoma of committed natural killer cell precursor origin: A case report. Cancer 77:2592-2603.
28. Jaffe ES (1995). Nasal and nasal-type NK/T-cell lymphoma: A unique form of lymphoma associated with the Epstein-Barr virus. Histopathology 27:581-583.
29. Jaffe ES (1996). Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 87:1207-1210.
30. Jaffe ES, Chan JKC, Su IJ, Frizzera G, Mori S, Feller AC, and Ho FCS (1996). Report on the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 20:103-111.
31. Jaffe ES, Lipford EH, Margolick JB, Longo DL, and Fauci AS (1989). Lymphomatoid granulomatosis and angiocentric lymphoma: A spectrum of post-thymic T-cell proliferations. Semin Respir Med 10:167-172.
32. Kanavaros P, Lescs MC, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet JP, Reyes F, and Gaulard P (1993). Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 81: 2688-2695.
33. Kobashi Y, Nakamura S, Sasajima Y, Koshikawa T, Yatabe Y, Kitoh K, Mori S, Ueda R, Yamabe H, and Suchi T (1996). Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occurring in sites other than the upper and lower respiratory tract. Histopathol 28:111-120.
34. Koiwai O (1995). Novel leukemic lymphoma with probable derivation from immature stage of natural killer (NK) lineage in an aged patient. Hematol Oncol 13:1-11.
35. Lanier LL, Chang C, Spits H, and Phillips JH (1992). Expression of cytoplasmic CD∈ proteins in activated human adult NK cells and CD3γ,δ,∈ complexes in fetal NK cells: Implications for the relationship of NK and T lymphocytes. J Immunol 14:1876-1880.
36. Lesley J, Hyman R, and Kincade PW (1993). CD44 and its interaction with the extracellular matrix. Adv Immunol 54: 271-335.
37. Mäenpää A, Jääskeläinen J, Carpén O, Patarroyo M, and Timonen T (1993). Expression of integrins and other adhesion molecules on NK cells: Impact of IL-2 on short- and long-term cultures. Int J Cancer 53:850-855.
38. 1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 14:2077-2086.
39. Mori N, Yatabe Y, Oka K, Kinoshita T, Kobayashi T, Ono T, and Asai J (1996). Expression of perform in nasal lymphoma: Additional evidence of its natural killer cell derivation. Am J Pathol 149:699-705.
40. + putative natural killer cell lymphomas: Production of cytolytic effectors and related proteins mediating tumor cell apoptosis? Hum Pathol 28:1276-1282.
41. Orteu CH, Li W, Allen MH, Smith NP, Barker JN, and Whittaker SJ (1997). CD44 variant expression in cutaneous T-cell lymphoma. J Cutan Pathol 24:342-349.
42. Parker GA, Crook T, Bain M, Sara EA, Farrell PJ, and Allday MJ (1996). Epstein-Barr virus nuclear antigen (EBNA)SC is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 13:2541-2549.
43. Phillips JH, Hori T, Nagler A, Bhat H, Spits H, and Lanier LL (1992). Ontogeny of human natural killer cells: Fetal NK cells mediate cytolytic function and express cytoplasmic CDS∈, δ proteins. J Exp Med 175:1055-1066.
44. 1 cyclins. Cell 73:1059-1065.
45. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO 13:3321-3328.
46. Spits H, Lanier LL, and Phillips JH (1995). Development of human T and natural killer cells. Blood 85:2654-2670.
47. Stauder R, Eisterer W, Thaler J, and Günthert U (1995). CD44 variant isoforms in non-Hodgkin's lymphoma: A new independent prognostic factor. Blood 85:2885-2899.
48. Suzumiya J, Takeshita M, Kimura N, Kikuchi M, Uchida T, Hisano S, Eura Y, Kozuru M, Nomura Y, Tomita K, Komiyama S, and Okumura M (1994). Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 83:2255-2260.
49. Tamura H, Ogata K, Mori S, An E, Tajika K, Sugisaki Y, and Dan K (1998). Lymphoblastic lymphoma of natural killer cell origin, presenting as pancreatic tumour. Histopathol 32:508-511.
50. Tan PHS, Santos EB, Rossbach HC, and Sandmaier BM (1993). Enhancement of natural killer activity by an antibody to CD44. J Immunol 150:812-820.
51. Tsuchiyama J, Yoshino T, Mori M, Kondoh E, Oka T, Akagi T, Hiraki A, Nakayama H, Shibuya A, Ma Y, Kawabata T, Okada S, and Harada M (1998). Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection. Blood 92:1374-1383.
52. Vardiman JW (1992). Chronic myelogenous leukemia and the myeloproliferative disorders. In: Knowles DM, editor. Neoplastic Hematopathology. Baltimore: Williams & Wilkins, 1405-1438.